The lawsuit, filed in response to alleged material misrepresentations, claims that Cogent’s reported optical wavelength backlog was largely inflated. According to the complaint, most orders were unlikely to convert into revenue, and many customers were either unable or unwilling to accept delivery. These discrepancies reportedly left the company unable to meet its stated revenue and margin targets, while also undermining the fundamental basis for its long-standing dividend policy.

Beyond operational concerns, the litigation highlights risks related to executive stock management. It alleges that David Schaeffer engaged in high-risk pledging activities involving vast quantities of Cogent shares, creating an undisclosed risk of forced sales that could suppress the stock price once the company’s underlying financial health became clear. Investors wishing to serve as lead plaintiff in this action must move the Court no later than September 21, 2026. Participation does not require out-of-pocket fees, as the firm operates on a contingency basis. No class has yet been certified, and investors retain the right to select their own counsel or remain absent members while the case proceeds.